Health, Education & Government Life Sciences & Pharma Pharmaceutical Manufacturing & Labs

Lab Automation

Regulated development and commercialization journeys where clinical, quality, and market access align.

Example organizations in this space: Beckman Coulter Hamilton Robotics Tecan Agilent

This interactive experience is the shipped product itself — the same application code customers run in production, mounted read-only in your browser over a real sample journey. Not a video, not a mockup: because the demo and the product are one codebase, it can never drift from the real thing.

Inside this journey
  1. Laboratory Outcome Discovery

    Align on current workflows, throughput constraints, assay variability sources, integration needs, and measurable success criteria.

    Discovery Questions

    Quick orientation, your lab and goals

    • Tell me briefly about your lab's primary throughput goals and which assays drive them
    • How many samples or plates do you process in a typical week? Options: <500 samples/week, 500-2,000, 2,000-10,000, 10,000-50,000, >50,000
    • Who on your team owns day-to-day liquid handling and method setup
    • Describe a recent week where throughput missed targets, what happened and why
    • Tell me which assay types and plate formats are most important for hitting your goals Options: 96-well, 384-well, 1536-well, Deep-well, Custom plate format, Multiple formats

    Where the bottlenecks hit hard

    • If your current liquid handling process had to be paused for a week, what immediate impact would you see on your discovery timelines
    • How often do manual pipetting steps create the largest delays in your workflow Options: Daily, Several times a week, Weekly, Monthly, Rarely
    • Walk me through the last time an instrument queue or backlog forced you to reassign experiments or resources
    • What breaks downstream when one assay run is delayed
    • Identify the throughput constraint that, if removed, would shorten your lead time most

    What is driving result variability right now

    • What part of your assay setup contributes most to run-to-run variability, and how do you know
    • How do you currently measure assay reproducibility, and which metrics matter most to you Options: Coefficient of variation (CV), Z-prime, Signal to background, Percent failure rate, Other
    • Provide an example of a protocol where manual technique created a measurable shift or outlier
    • Provide a short inventory of reagents or steps most sensitive to volume or timing, and how often they cause failures
    • If a validated automation change reduced CV by 30 percent in a critical assay, what would that be worth to your team in time or budget

    Integration and data flow reality

    • What's the single integration failure that would derail a deployment in your environment
    • Identify the systems the automation must connect to, for example your LIMS, plate readers, or analysis pipeline Options: LIMS, Plate reader or data acquisition, Internal analysis pipeline, Inventory system, Scheduling software, Other
    • Do you have APIs, middleware, or a dedicated integration owner for those systems Options: APIs available and documented, APIs available but undocumented, No APIs, middleware available, Only manual file exchange, Not sure
    • How mature is your data model for plate maps and result files, and who maintains it Options: Well defined and versioned, Partially defined, Ad hoc CSVs, No standard model
    • Who is responsible for granting network access and API credentials during implementation
    • What's the consequence if CSV or API payloads change mid-validation

    Real constraints that could stop this

    • Describe the hard infrastructure limits in your lab that would prevent installing a new automation cell
    • How many dedicated power circuits, square feet of bench space, and network ports can you commit within a standard installation window Options: 1, 2, 3, 4+, Not available
    • Are there safety, biosafety, or regulatory reviews that must sign off before equipment arrives Options: Biosafety committee, Environmental health and safety, Regulatory quality review, Export controls, None, Not sure
    • Please provide the person who will act as the site owner for installation tasks and approvals, include role and contact details
    • List contractual restrictions or existing maintenance agreements that could block vendor access
    • If access to the site cannot be granted during your target window, what is the alternative Options: Delay install, Perform remote integration then ship, Use temporary lab space, Cancel project, Other

    Competitive landscape and alternatives you are weighing

    • What alternatives, including in-house fixes, are you actively weighing right now Options: Stick with incumbent instruments, Build in-house automation, Other vendors, Pilot with consulting partner, Delay investment, Other
    • List the incumbent approach and any vendors or internal teams you are evaluating
    • Explain the features or outcomes that would have to remain true for you to keep your current approach
    • Has anyone proposed solving this internally instead of using an external vendor, and if so what would that plan require Options: Yes, with existing staff, Yes, with a new hire plan, No, Not yet discussed
    • What unmet promise or change would make you walk away from changing platforms today

    How you will call this a win

    • If a pilot proves you can hit your target throughput and reproducibility, what stops you from placing an order that week Options: Budget approval, Procurement timelines, Technical acceptance, Executive sign-off, Nothing, ready to sign
    • List the measurable criteria that must be met during acceptance testing for your team to sign off
    • How do you quantify the value of researcher time freed from manual pipetting Options: Time saved per run, Headcount reduction, Faster time to result, Cost per sample, Other
    • Provide the stakeholders in procurement or finance who must approve the budget and state their approval thresholds
    • What is your preferred pilot length and which outcomes would accelerate the commercial review Options: 1 week, 2-4 weeks, 1-3 months, 3+ months, Unsure
    • If the pilot misses one critical metric but exceeds others, will you proceed, pause, extend the pilot, or redefine acceptance Options: Proceed, Pause and rework scope, Extend pilot, Cancel project

    Practical next steps and timing

    • What timeline would push this from conversation to a signed agreement in your planning Options: Immediately, Within 1 month, 1-3 months, 3-6 months, Longer
    • What internal milestones or procurement windows must align for you to schedule installation within three months
    • Provide the name and role of the day-to-day contact who will coordinate scheduling and validation
    • What risks do you expect during the first 90 days after installation, and what mitigation plans exist today
    • Select the support model you prefer after deployment and identify SLA elements that are non-negotiable Options: Remote support only, On-site engineer visits, Dedicated application scientist, Training plus remote support, Other
    • How soon can you make required data and network credentials available after contract execution Options: Immediately, Within 1 week, 1-2 weeks, 2-4 weeks, Longer than 4 weeks
  2. Solution Experience

    Walk through how automated workflows, method development, and integrations will reduce manual pipetting, increase throughput, and improve assay reproducibility using the buyer's real use cases.

    Solution Experience

    • Solution Experience Session
    • Confirm the current state and its cost to your team
    • You confirm the restated current state and agree on the concrete costs it imposes on your team.
    • Run the sample throughput forecast on the provided assay and deliver a comparison showing expected throughput, researcher-hours saved, and projected reduction in repeat runs.
    • You confirm the demonstrated workflow removes the manual pipetting steps and materially reduces the variability you described.
    • Walk through an automated run of your representative assay
    • Provide a representative assay protocol, consumable list, and five recent raw run files for use in method development and benchmarking.
    • You accept the proposed integration approach for shipping results to your LIMS and identify outstanding integration questions to resolve before deployment.
    • Show expected throughput and error-rate comparison for the buyer's workload
    • Identify the integration owner and provide the LIMS endpoint details, preferred data schema, and a 2-hour window for connectivity testing.
    • Map integrations and data flow to your LIMS and readers
    • Draft a scope summary that lists the proposed automated steps, method development milestones, and acceptance criteria for a pilot.
    • Validate that this matches your requirements
    • Solution Experience Session
    • Solution Experience Deck
    • Solution Brief
    • meeting
    • slides
    • document
  3. Solution Scope

    Define equipment configuration, software integrations (LIMS, readers), method development deliverables, installation responsibilities, validation protocols, and training scope.

    Scope Configuration

    • Install Robotic Liquid Handling Platform
    • Deploy Integrated Workcell and Plate Handling Hardware
    • Program and Deploy Pipetting Protocols
    • Configure Nano- and Multi-Channel Dispensing Modules
    • Integrate Instruments with LIMS and Data Systems
    • Perform Method Development and Assay Transfer
    • Provide Operator Training and Certification
    • Deliver IQ/OQ/PQ Validation Protocols and Reports
    • Install Automated Plate Storage and Retrieval Systems
    • Deploy Laboratory Automation Control Software
    • Install Maintenance, Remote Monitoring, and Support Tools
    • Arrange Equipment Financing and Lease Options

    Scope Questions

    Install Robotic Liquid Handling Platform

    • Specify the available electrical service at your installation location (voltage and phases) Options: 110 V single-phase, 208 V three-phase, 230 V single-phase, Other - describe
    • Provide the bench footprint and clearance available for the platform (width x depth x overhead mm)
    • Indicate the primary plate formats and vessel types used in this workflow (cite well counts and plate materials) Options: 96-well (polystyrene), 384-well (polypropylene), 1536-well, Tubes or deep-well plates, Mixed formats
    • Identify any biosafety or environmental constraints for the install location (e.g., BSC class, temperature control, humidity limits)
    • Describe your consumables and tip management plan at the site (on-site bulk, managed inventory, single-use only) Options: On-site bulk stock, Vendor-managed inventory, Just-in-time delivery, Lab-managed reorder
    • Confirm which installation acceptance evidence will validate a successful platform install (site acceptance test checklist, demonstration with representative assay, signed IQ/OQ) Options: SAT checklist signed by site owner, Operational demonstration with representative assay, IQ/OQ completion certificate, Other - describe

    Deploy Integrated Workcell and Plate Handling Hardware

    • List the plate handling components required in the workcell (robot arm, stackers, plate hotels, conveyors) Options: Single-arm plate handler, Multi-arm plate handler, Stacker/hotel, Conveyor integration, Reader loader
    • Estimate the maximum simultaneous plate throughput you expect from the workcell (plates per hour) Options: <50 plates/hr, 50-200 plates/hr, 200-500 plates/hr, >500 plates/hr
    • Select the physical integration constraints the workcell must respect (lab doorway width, floor load, rack height) Options: Doorway width limit, Floor load limit (kg/m2), Row/rack height restrictions, Crane/lift required
    • Supply the plate stacker capacity and plate carrier dimensions required by your assays
    • Name any adjacent instruments the workcell must interface mechanically (incubators, readers, sealers) Options: Microplate reader, Microplate sealer, Incubator/shaker, Automated freezer, Other - list
    • Attach any site access constraints that affect delivering large modules (loading dock restrictions, elevator limits, after-hours delivery windows)

    Program and Deploy Pipetting Protocols

    • Identify the assay steps you expect to automate in the pipetting protocol (dilution series, compound transfers, reagent additions, washes) Options: Dilution series, Compound transfers, Reagent additions, Plate washing, Mixing/incubation steps
    • Specify the target liquid volume ranges and accuracy/precision thresholds for each step (for example, 1-10 µL with CV <5%)
    • Indicate the plate maps and barcode formats you will provide for protocol mapping Options: Well-by-well plate map CSV, Barcode per plate, Embedded plate layout files, Manual mapping on site
    • Describe any tip types or low-volume dispensing technologies required by your methods (filtered tips, low-retention, fixed tips) Options: Filtered disposable tips, Low-retention tips, Fixed reusable tips, Acoustic dispense adjunct
    • Select your preferred method deployment model for protocols (we deliver final methods, collaborate on tuning, handoff source code only) Options: Fully delivered and validated by us, Co-development with your team, Method files only for your engineers
    • Supply the expected run-size and batching rules for each protocol (plates per run, overnight runs, continuous processing)

    Configure Nano- and Multi-Channel Dispensing Modules

    • Indicate which nano- or multi-channel dispense modes you require (low-nL acoustic, 8-channel, 96-channel) Options: Nano/acoustic dispense, 8-channel pipetting, 96-channel pipetting, Custom manifold
    • Provide the minimum and maximum dispense volumes for the high-channel steps and the required volume CV thresholds
    • Identify any carrier fluids, solvents, or DMSO concentrations used that affect dispense head compatibility Options: Aqueous buffers only, Organic solvents present, DMSO >10%, Other - list
    • Describe your aspiration and wash requirements for multi-channel heads (number of wash cycles, solvent type, tip change frequency)
    • Select which acceptance checks you require for dispensing calibration (volume gravimetric check, dye-based imaging, plate-based QC) Options: Gravimetric volume check, Dye absorbance-based QC, Plate-count imaging, Internal standard spike recovery
    • Identify environmental controls needed for nano-dispense accuracy (temperature control, enclosure, humidity limits) Options: Temperature-controlled enclosure, Humidity control, No special controls required, Other - describe

    Integrate Instruments with LIMS and Data Systems

    • Specify the LIMS or lab data system endpoint(s) you need integrated (include API type, base URL, and authentication method)
    • Identify the data objects to be exchanged with your LIMS (plate barcode, well-level results, run metadata, QC flags) Options: Plate barcode, Well-level results, Run metadata, QC flags, Raw instrument logs
    • Provide the file formats and frequency for data exchange (real-time via API, batch CSV every run, HL7-style messages) Options: Real-time API, Batch CSV after run, SFTP drop, Other - describe
    • Identify the security and network constraints for integration (VLAN, VPN, static IP, port restrictions) Options: VLAN access, VPN required, Static IP allowed, Outbound only
    • Indicate who in your IT or LIMS team will own API credentials and who will approve test accounts
    • Select whether you require our delivered integration to include automated reconciliation of plate-to-LIMS mapping Options: Yes, include automated reconciliation, No, we will reconcile manually, Partial - discuss

    Perform Method Development and Assay Transfer

    • Identify the representative assays you will transfer (assay name, readout type, expected signal window)
    • Describe the acceptance criteria for method transfer (target CV, Z-prime, signal-to-noise ratios)
    • Indicate the number of iterative optimization cycles included in the scope (rounds of pipetting/mixing parameter tuning) Options: 1 round, 2 rounds, 3 rounds, More than 3 - define
    • Provide the sample types and matrix considerations for method development (cell lysate, serum, compound DMSO) Options: Aqueous buffer, Cell lysate, Serum/plasma, High DMSO content
    • Select the deliverables you expect from method development (scripted protocol file, validation report, SOP update) Options: Protocol file for robot, Validation report with QC data, Updated standard operating procedure (SOP), Training-ready method deck
    • Identify who will provide control materials and reference plates for transfer testing (your lab supplies, we ship controls) Options: You provide materials, We provide materials, Shared responsibility

    Provide Operator Training and Certification

    • Name the roles to be trained and certified (operators, lab managers, service engineers)
    • Specify the training format preferred for your staff (on-site instructor-led, remote instructor-led, self-paced e-learning) Options: On-site instructor-led, Remote instructor-led, Self-paced e-learning, Hybrid
    • Indicate the target class size and number of sessions required for operator competency Options: 1-2 people per session, 3-6 people per session, 7+ people per session
    • Describe the certification criteria you expect operators to meet (practical run, written quiz, supervised runs) Options: Practical run sign-off, Written knowledge check, Supervised production runs, Other - describe
    • Provide the documentation artifacts you require post-training (attendance roster, competency checklist, training slides) Options: Attendance roster, Competency checklist, Training slides and videos, Certificate of completion
    • Identify if refresher training or train-the-trainer capability is required within scope Options: Refresher training included, Train-the-trainer included, Neither

    Deliver IQ/OQ/PQ Validation Protocols and Reports

    • State which qualification phases you require documented in deliverables (installation qualification, operational qualification, performance qualification) Options: IQ, OQ, PQ, IQ+OQ only
    • Provide any regulatory or compliance regimes your lab follows that must be reflected in validation (GLP, GMP, 21 CFR Part 11, ISO) Options: GLP, GMP, 21 CFR Part 11, ISO 17025, Other - list
    • Indicate the acceptance thresholds for PQ runs (e.g., Z-prime >0.5, CV <10% across control wells)
    • Identify the evidence package you require for final acceptance (raw run files, summary report, signed IQ/OQ/PQ) Options: Raw run files, Summary validation report, Signed IQ/OQ/PQ protocol, SOP updates
    • Confirm the party responsible for retaining validation records and how long records must be archived Options: You retain records, We retain & hand over, Shared retention - define policy
    • Provide the scheduled windows you prefer for executing IQ/OQ/PQ activities (dates or typical lab downtime windows)

    Install Automated Plate Storage and Retrieval Systems

    • Identify the required storage capacity in plates or racks and the expected retrieval throughput
    • Specify physical constraints for storage system installation (floor footprint, rack height, seismic or loading limits)
    • Indicate the plate temperature control requirements for storage (room temperature, 4°C, -20°C, -80°C) Options: Room temp, 4 °C refrigerated, -20 °C freezer, -80 °C ultra-low
    • Describe required integration behavior between the storage system and the workcell (automated handoff, manual staging, barcode handshake) Options: Automated handoff, Manual staging, Barcode-based handshake, Other - describe
    • Identify any sample tracking or chain-of-custody fields that must be preserved during retrieval operations Options: Sample ID, Matrix type, Operator ID, Time stamp, QC flags
    • Provide any environmental monitoring or alarm notification preferences for storage (email alerts, SNMP traps, on-screen alarms) Options: Email alerts, SNMP traps, SMS notifications, On-screen alarms

    Deploy Laboratory Automation Control Software

    • Identify the orchestration features you require (scheduling, queue management, resource reservation, error handling) Options: Job scheduling, Queue management, Resource reservation, Automated error recovery
    • Specify required user roles and permission levels within the control software (operator, supervisor, admin, service)
    • Indicate preferred deployment model for the software (on-premises server, virtual machine, cloud-hosted) and any constraints Options: On-premises server, VM in your environment, Cloud-hosted, Hybrid
    • Describe the expected integration points with your scheduling and LIMS systems (API endpoints, webhooks, file drop) Options: API endpoints, Webhooks, File drop (SFTP), None required
    • Provide your acceptable single-point-of-failure tolerance and expected uptime for the orchestration layer (e.g., 99.9% SLA) Options: Standard uptime (99%), High availability (99.9%+), No downtime windows allowed, Custom SLA - discuss
    • Identify the data retention and export requirements for run history and audit logs Options: 30 days, 90 days, 1 year, Custom retention period
  4. Mutual Commit

    Finalize commercial terms, acceptance criteria, support SLAs, responsibilities, and deployment milestones required to proceed.

    Agreement Modules

    • Master Services Agreement (MSA)
    • Statement of Work (SOW)
    • Purchase Agreement / Order Confirmation
    • Service Level Agreement (SLA)
    • Acceptance Test Plan & Acceptance Certificate
    • Project Schedule & Deployment Milestones
    • Payment Schedule & Commercial Terms
    • Warranty & Maintenance Agreement
    • Change Order Agreement
    • Training & Knowledge Transfer Agreement
    • Data Processing Addendum (DPA) — conditional
    • Regulatory Compliance & Validation Addendum — conditional
  5. Deployment

    Operationalize installation, integrations, validation, and operator training with readiness checks and configuration locks.

    1. Pre-Deployment Readiness

      Capture concrete readiness facts — lab footprint, power/network access, safety/compliance requirements, schedule windows, and named owners for site activities.

      Pre-Deployment Questions

      Environment and site access

      • How many physical sites will receive equipment for this deployment? Options: Single site, Multiple sites
      • For each site, provide the internal site identifier, building/room for install, and the named site contact (name, role, email). This is required to schedule site surveys and access permits.

      Infrastructure and connectivity

      • What is the electrical readiness at the install location(s)? Select all statements that apply (different sites may have different states). Options: Dedicated laboratory circuit already available, Dedicated circuit will be provisioned before install, Shared circuit — needs assessment, Buyer requires vendor assistance to provision, Unknown / site survey required
      • Which network connectivity options are available at the install location(s)? Select all that apply (we will not collect credentials here). Options: Wired LAN with internet, Wired LAN without internet (air-gapped), VLAN/segmented lab network, Wireless only, No network — vendor to provide connectivity, Unknown / IT confirmation required
      • Provide the named on-site IT/network owner who will approve firewall/VLAN changes and the preferred contact window for scheduling coordination.

      Data and configuration

      • Which categories of third-party systems will this deployment integrate with? Select all that apply. Options: LIMS, ELN (electronic lab notebook), Plate reader / analysis software, Data warehouse / BI, Instrument management / CMMS, None
      • Who owns the source-of-truth for sample/plate mapping and method parameters? This determines who delivers final mappings prior to validation. Options: Buyer will deliver finalized mapping and parameters, Buyer will deliver provisional mapping and needs seller support, Seller to own mapping & method parameter finalization, Undecided — needs a joint decision

      People, approvals, and schedule constraints

      • Provide the primary buyer project owner (name and role) who will approve site access, accept system validation, and confirm training completion.
      • Which site-level compliance or safety approvals are required before on-site work? Select all that apply. Options: Biosafety committee (BSL) approval, Chemical safety approval (SDS/process), Radiation/x-ray safety approval, EHS/site access badge, IT security approval, None
      • Are there any site blackout windows, plant shutdowns, or restricted dates we must avoid for on-site work? If yes, indicate whether buyer will provide specific date ranges for scheduling. Options: No — no blackout windows, Yes — buyer will provide blackout date ranges for scheduling
    2. Configuration Details

      Lock exact configuration values the deployment team will use — integration endpoints, API credentials, plate maps, method parameters, and data flows to LIMS/analysis tools.

      Configuration Details

      ENVIRONMENTS & ENDPOINTS

      • Enter the exact deployment environment identifier the build will target (single value used by the deployment scripts; e.g., 'prod-lab-1' or 'staging-qa').
      • Instrument control server URL the deployment should configure (format: https://hostname[:port]/api). Default is NONE if the instrument is controlled via local network-only setup — enter NONE in that case.

      INTEGRATIONS & AUTHENTICATION

      • Select the LIMS/data-repository integration type the deployment will enable (choose one). Options: REST API (JSON), SFTP file drop (CSV/TSV), Database direct (ODBC/JDBC), Message queue (AMQP), None
      • Enter your LIMS or analysis endpoint URL/path (format: https://hostname/... OR sftp://host/path OR jdbc:subprotocol://host). Default is NONE if not integrating.
      • Select the authentication method to use for the LIMS/analysis integration (the secret/token itself will be exchanged via your secrets manager at handoff; do NOT paste secrets here). Options: API key (secret exchanged via secrets manager), OAuth2 (collect client ID here; secret exchanged securely), Service account (integration account name; secret exchanged securely), Username (enter account name here; password exchanged securely), None
      • Enter the non-secret identifier for the integration credential the deployment will reference (client ID, integration account name, or service account name). Enter NONE if not applicable.

      PLATE FORMATS, MAPPINGS & METHOD PARAMETERS

      • Select the primary plate format the deployment should configure (choose one). Default is 96-well. Options: 96-well (default), 384-well, 1536-well, Custom
      • If you selected 'Custom' above, enter the plate layout as rows x columns (format exactly: 'rowsxcolumns', e.g., '16x24' for a 384). If not custom, enter NONE.
      • Default minimum dispense volume the method should use (numeric, in µL). Default is 0.5 — enter a number only (e.g., 0.5).
    3. System Installation & Validation

      Install instruments, integrate software and readers, execute validation protocols, and deliver operator training with clear owners, sequencing, and milestones.

  6. Success

    Review outcomes against success metrics, capture issues and enhancement requests, and schedule ongoing support and method optimization.

    Success Reviews

    • Go-live Health Check (weeks 1-4)
    • First Outcomes Measurement (weeks 4-10)
    • Acceptance Gate Review (around day 90)
    • Quarterly Operational Review
    • Annual Success Review and Method Optimization Planning

    Issues & Enhancements

    • Ensure support tickets impacting operations are assigned resolution dates and tracked in the shared tracker.
    • Update the integration error log and confirm fixes to LIMS data flows.
    • Restate acceptance criteria and numeric targets recorded in Mutual Commit
    • Produce a documented pass or fail for each acceptance criterion recorded in Mutual Commit.
    • If any criteria fail, capture a concrete remediation plan with owners and dates that closes the acceptance loop.
    • Capture the formal acceptance decision and named signatory when the engagement requires signatory ratification.
    • Publish the acceptance decision record, including per-criterion pass/fail status and evidence links.
    • Create remediation tickets for any failed criteria with due dates and verification steps.
    • Schedule the first Quarterly Operational Review on the post-acceptance cadence.
    • Trend review of throughput and manual work reduction
    • Confirm whether throughput and manual-hours-saved are meeting the trajectory toward Mutual Commit targets and identify exceptions.
    • Prioritize the enhancement and optimization backlog for the next quarter with clear owners and delivery windows.
    • Re-confirm deployment completion and owners
    • Publish the quarterly trends dashboard and the prioritized enhancement backlog.
    • Open or update remediation tickets for any operational issues with agreed SLA target dates.
    • Schedule focused method optimization runs and capture expected measurement windows for validation.
    • Annual outcomes versus Mutual Commit targets
    • Confirm annual attainment of assay CV and researcher hours‑saved targets as recorded in Mutual Commit, or document variance and plan to close it.
    • Agree a prioritized method optimization roadmap with timelines and verification checkpoints.
    • Ensure ongoing support and review cadence is scheduled and acknowledged by all operational owners.
    • Publish the annual outcomes report with variance analysis and the approved method optimization roadmap.
    • Convert approved optimizations into scheduled validation runs with target success criteria and dates.
    • Confirm support SLA contact points and publish the yearly review schedule.
    • Confirm deployment and validation close‑out items with owners and target dates.
    • Document top 3 early defects or blockers and agree immediate remediation actions.
    • Verify operator training reach and readiness for first outcome runs.
    • Publish a deployment close‑out checklist with owners and target dates.
    • Log all observed errors into the support tracker with severity and temporary workarounds.
    • Confirm the date range and required data sources for the First Outcomes Measurement meeting.
    • Recap acceptance targets recorded in Mutual Commit
    • Determine whether daily plate throughput and assay CV are trending to the Mutual Commit targets or require remediation.
    • Have a documented root cause for each KPI shortfall and an agreed remediation plan with dates.
    • Confirm the dataset and owners required for the Acceptance Gate meeting.
    • Deliver the measurement dataset and analysis summary for the agreed window to the shared workspace.
    • Execute assigned remediation steps and report interim results before the Acceptance Gate meeting.
    • Long‑running issues and enhancement backlog review
    • Assay reproducibility and method adjustments
    • Present first measurement data
    • Validation handover summary
    • Present consolidated outcome data vs each criterion
    • Open issues and support SLA adherence
    • Operator onboarding and training status
    • Document acceptance decision and signatory capture
    • Integration and data flow health
    • Method optimization roadmap
    • Early stability and error signals
    • Remediation plan for any failed criteria
    • Enhancement request backlog and prioritization
    • Support model review and ongoing cadence
    • Root cause analysis for any gaps
    • Confirm post-acceptance support and optimization cadence
    • Open issues, temporary workarounds, and next steps
    • Agree remediation actions and timeline
    • Agree next quarter operational priorities and checkpoints
    • Closeout actions and next meeting schedule
    • Confirm readiness criteria for Acceptance Gate
    • Agree timing for First Outcomes Measurement
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.